DataMEDS AI, Inc.
MEDS
$0.94
-$0.02-1.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -175.21% | 76.13% | -542.99% | -1,738.15% | -1,061.85% |
| Total Depreciation and Amortization | -55.58% | -55.56% | 24.01% | 76.59% | 6,171.88% |
| Total Amortization of Deferred Charges | 86,088.50% | 6,622.17% | -- | -- | -- |
| Total Other Non-Cash Items | 134.47% | -95.72% | 1,871.89% | 101,581.65% | -- |
| Change in Net Operating Assets | 6.22% | -46.22% | -1,587.72% | 99.10% | 205.08% |
| Cash from Operations | -39.21% | -153.31% | -139.85% | -209.42% | -730.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.55% | 24.90% | -29.38% | -1.84% | -175.94% |
| Cash from Investing | -83.55% | 24.90% | -131.82% | 30.01% | -653.71% |
| Total Debt Issued | -53.46% | 452.61% | 22.41% | -- | 7,144.96% |
| Total Debt Repaid | 91.87% | -526.51% | -2,219.91% | -1,415.20% | -- |
| Issuance of Common Stock | -99.82% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -397.02% | -- | 507.02% | -191.18% | 235.31% |
| Cash from Financing | 4,747.77% | 16.68% | 14.89% | 114,680.00% | 121.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.69% | -99.38% | -1,879.80% | 424.47% | -829.34% |